2018
Meningeal Lymphatic Vessel Flow Runs Countercurrent to Venous Flow in the Superior Sagittal Sinus of the Human Brain.
Kuo PH, Stuehm C, Squire S, Johnson K. 2018. Meningeal Lymphatic Vessel Flow Runs Countercurrent to Venous Flow in the Superior Sagittal Sinus of the Human Brain. Tomography. 4:99–104. doi:10.18383/j.tom.2018.00013.
Naturalistically observing noncancer conversations among couples coping with breast cancer.
Robbins ML, Karan A, López AM, Weihs KL. 2018. Naturalistically observing noncancer conversations among couples coping with breast cancer. Psychooncology. 27:2206–2213. doi:10.1002/pon.4797.
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW. 2018. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain. 159:1814–1823. doi:10.1097/j.pain.0000000000001278.
Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis.
Menghrajani K, Boonstra PS, Mercer JA, Perkins C, Gowin KL, Weber AA, Mesa R, Gotlib JR, Wang L, Singer JW, et al. 2018 Sep. Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis. Leuk Lymphoma.:1–7. doi:10.1080/10428194.2018.1509315.
Social support and breast cancer screening in rural Appalachia.
Smalls BL, Aroh A, McQuerry K, Adegboyega A, Schoenberg N, Hatcher J. 2018. Social support and breast cancer screening in rural Appalachia. Psychooncology. 27:2281–2288. doi:10.1002/pon.4828.
Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with Antitumor Activity.
Peters TL, Tillotson J, Yeomans AM, Wilmore S, Lemm E, Jiménez-Romero C, Amador LA, Li L, Amin AD, Pongtornpipat P, et al. 2018. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with Antitumor Activity. Clin Cancer Res. 24:4256–4270. doi:10.1158/1078-0432.CCR-17-3645.
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Persky DO, Li H, Rimsza LM, Barr PM, Popplewell LL, Bane CL, Von Gehr A, LeBlanc M, Fisher RI, Smith SM, et al. 2018. A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806. Am J Hematol. 93:486–493. doi:10.1002/ajh.25010.
Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI).
Hamann HA, Shen MJ, Thomas AJ, Craddock Lee SJ, Ostroff JS. 2018. Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health. 3:195–203. doi:10.1037/sah0000089.
Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line.
Malm SW, Amouzougan EA, Klimecki WT. 2018. Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line. Toxicol In Vitro. 50:383–390. doi:10.1016/j.tiv.2018.04.008.
Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis.
Bergsma A, Ganguly SS, Dick D, Williams BO, Miranti CK. 2018. Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis. Bone. 113:105–113. doi:10.1016/j.bone.2018.05.020.
Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions.
Dellinger MT, Witte MH. 2018. Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions. Clin Exp Metastasis. 35:419–424. doi:10.1007/s10585-018-9907-9.
Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.
Das L, Gard JMC, Prekeris R, Nagle RB, Morrissey C, Knudsen BS, Miranti CK, Cress AE. 2018. Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer. Mol Cancer Res. 16:1319–1331. doi:10.1158/1541-7786.MCR-17-0589.
Potential Underuse of the Sentinel Lymph Node Biopsy for High-Risk Squamous Cell Carcinoma of the Skin.
Glazer AM, Stratton D, Curiel-Lewandrowski C. 2018. Potential Underuse of the Sentinel Lymph Node Biopsy for High-Risk Squamous Cell Carcinoma of the Skin. JAMA Dermatol. 154:972–973. doi:10.1001/jamadermatol.2018.1807.
The cAMP-induced G protein subunits dissociation monitored in live Dictyostelium cells by BRET reveals two activation rates, a positive effect of caffeine and potential role of microtubules.
Tariqul Islam AFM, Yue H, Scavello M, Haldeman P, Rappel W-J, Charest PG. 2018. The cAMP-induced G protein subunits dissociation monitored in live Dictyostelium cells by BRET reveals two activation rates, a positive effect of caffeine and potential role of microtubules. Cell Signal. 48:25–37. doi:10.1016/j.cellsig.2018.04.005.
Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
Knitter JR, Erly WK, Stea BD, Lemole GM, Germano IM, Doshi AH, Nael K. 2018. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation. AJR Am J Roentgenol. 211:168–175. doi:10.2214/AJR.17.18890.
NRF2 and the Hallmarks of Cancer.
de la Vega MR, Chapman E, Zhang DD. 2018. NRF2 and the Hallmarks of Cancer. Cancer Cell. 34:21–43. doi:10.1016/j.ccell.2018.03.022.
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.
Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, et al. 2018. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 128:2787–2801. doi:10.1172/JCI95407.
Task-based design of a synthetic-collimator SPECT system used for small animal imaging.
Lin A, Kupinski MA, Peterson TE, Shokouhi S, Johnson LC. 2018. Task-based design of a synthetic-collimator SPECT system used for small animal imaging. Med Phys. 45:2952–2963. doi:10.1002/mp.12952.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018).
Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR. 2018. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum. 61:755–774. doi:10.1097/DCR.0000000000001114.
Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. 2018. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas. 112:53–63. doi:10.1016/j.maturitas.2018.03.012.
Oncolytic Viruses for Multiple Myeloma Therapy.
Calton CM, Kelly KR, Anwer F, Carew JS, Nawrocki ST. 2018. Oncolytic Viruses for Multiple Myeloma Therapy. Cancers (Basel). 10. doi:10.3390/cancers10060198.
Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices.
Weinstein RS, Krupinski EA, Doarn CR. 2018. Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices. Med Clin North Am. 102:533–544. doi:10.1016/j.mcna.2018.01.002.
Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D, El-Ghamry MN, Deb N, Thawani N, Shaver C, Mutyala S. 2018. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions. Brachytherapy. 17:601–608. doi:10.1016/j.brachy.2018.01.002.
Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction.
LoConte NK, Gershenwald JE, Thomson CA, Crane TE, Harmon GE, Rechis R. 2018 May. Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction. Am Soc Clin Oncol Educ Book.:88–100. doi:10.1200/EDBK_200093.
Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.
Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. 2018. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 8:7593. doi:10.1038/s41598-018-25879-7.